Epithelial Ovarian Cancer: A Five Year Review
Christos Arnaoutoglou, Kalliopi Dampala, Christos Anthoulakis, Evangelos Papanikolaou, Ioannis Tentas, Georgios Dragoutsos, Nikolaos Machairiotis, Paul Zarogoulidis, Aris Ioannidis, Dimitris Matthaios, Eleni Isidora Perdikouri, Dimitrios Giannakidis, Chrysanthi Sardeli, Stamatios Petousis, Panagoula Oikonomou, Christina Nikolaou, Charalampos Charalampidis, Konstantinos Sapalidis
Abstract
Ovarian cancer is a malignant disease that affects thousands of patients every year. Currently, we use surgical techniques for early-stage cancer and chemotherapy treatment combinations for advanced stage cancer. Several novel therapies are currently being investigated, with gene therapy and stem cell therapy being the corner stone of this investigation. We conducted a thorough search on PubMed and gathered up-to-date information regarding epithelial ovarian cancer therapies. We present, in the current review, all novel treatments that were investigated in this field over the past five years, with a particular focus on local treatment.